The news just came in. A third gene therapy trial for Leber Congenital Amaurosis caused by mutations in RPE65, carried out at the University of Florida, has proven safe, and has led to improvement of vision in 4 out of the 6 participants. Only a few days ago, the world of science was shaken by similar results obtained by 2 analogous trials conducted in London and in the US (see previous posts).
More to come for sure!
Sunday, May 04, 2008
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment